Evaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bovina y Buforina II.

Los péptidos antimicrobianos (PAMs) se han considerado como una estrategia de tratamiento antimicótica prometedora, ya que cuentan con baja capacidad para inducir resistencia, poseen varios mecanismos de acción, son de amplio espectro y su combinación con antifúngicos convencionales puede generar ef...

Full description

Autores:
Márquez Torres, Mateo
Tipo de recurso:
Trabajo de grado de pregrado
Fecha de publicación:
2022
Institución:
Colegio Mayor de Cundinamarca
Repositorio:
Repositorio Colegio Mayor de Cundinamarca
Idioma:
spa
OAI Identifier:
oai:repositorio.unicolmayor.edu.co:unicolmayor/5715
Acceso en línea:
https://repositorio.unicolmayor.edu.co/handle/unicolmayor/5715
Palabra clave:
Candida albicans
Quimeras
Lactoferricina bovina
BuforinaII
Péptidos antimicrobianos
Rights
closedAccess
License
Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2022
id UCOLMAYOR2_d0ea5552dda9cd57569cda3ae9baa803
oai_identifier_str oai:repositorio.unicolmayor.edu.co:unicolmayor/5715
network_acronym_str UCOLMAYOR2
network_name_str Repositorio Colegio Mayor de Cundinamarca
repository_id_str
dc.title.spa.fl_str_mv Evaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bovina y Buforina II.
title Evaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bovina y Buforina II.
spellingShingle Evaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bovina y Buforina II.
Candida albicans
Quimeras
Lactoferricina bovina
BuforinaII
Péptidos antimicrobianos
title_short Evaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bovina y Buforina II.
title_full Evaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bovina y Buforina II.
title_fullStr Evaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bovina y Buforina II.
title_full_unstemmed Evaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bovina y Buforina II.
title_sort Evaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bovina y Buforina II.
dc.creator.fl_str_mv Márquez Torres, Mateo
dc.contributor.advisor.none.fl_str_mv Estupiñán Torres., Sandra Mónica
Parra GiraldoClaudia Marcela, Claudia Marcela
Vargas Casanova, Yerly
dc.contributor.author.none.fl_str_mv Márquez Torres, Mateo
dc.subject.proposal.eng.fl_str_mv Candida albicans
Quimeras
topic Candida albicans
Quimeras
Lactoferricina bovina
BuforinaII
Péptidos antimicrobianos
dc.subject.proposal.spa.fl_str_mv Lactoferricina bovina
BuforinaII
Péptidos antimicrobianos
description Los péptidos antimicrobianos (PAMs) se han considerado como una estrategia de tratamiento antimicótica prometedora, ya que cuentan con baja capacidad para inducir resistencia, poseen varios mecanismos de acción, son de amplio espectro y su combinación con antifúngicos convencionales puede generar efecto sinérgico, sin embargo, como desventajas se encuentra altos costos de producción, fácil degradación proteolítica, toxicidad en células eucariotas y hemólisis sobre los glóbulos rojos. La Lactoferricina Bovina (LfcinB) es un PAM generado tras la hidrólisis proteica de Lactoferrina Bovina (LFB), por su parte la Buforina II (BFII) es un PAM aislado del estómago del sapo Bufo bufo gargarizans. Los péptidos mencionados anteriormente se les ha atribuido un gran potencial antimicrobiano. Con la finalidad de potenciar la actividad antifúngica, se diseñaron y sintetizaron quimeras ramificadas que contienen los motivos mínimos de ambos péptidos (LfcinB: RRWQWR y BFII: RLLR), además se evaluó su actividad hemolítica y el efecto de combinar estas quimeras con fluconazol. Como resultados se obtuvo que el péptido (RRWQWR)2KXRLLRRLLR presentó mayor actividad antifúngica (Concentración mínima inhibitoria y fungicida) CMI/CMF 50 µg/mL (15.27 µM)) en comparación con la quimera (RRWQWR)2KXRLLR (CMI/CMF de 100 µg/mL (36.56 µM) contra C. albicans sensible y resistente a fluconazol. La quimera (RRWQWR)2KXRLLR no exhibió actividad hemolítica mientras que (RRWQWR)2KXRLLRRLLR presentó porcentaje de hemólisis de 11.56% a la concentración de la CMI. Con respecto a la combinación de los péptidos quiméricos ramificados junto con fluconazol, se obtuvo sinergia con ambos péptidos cuando se evaluaron frente a C. albicans sensible a este antifúngico
publishDate 2022
dc.date.accessioned.none.fl_str_mv 2022-10-18T16:26:24Z
dc.date.available.none.fl_str_mv 2022-10-18T16:26:24Z
dc.date.issued.none.fl_str_mv 2022
dc.type.spa.fl_str_mv Trabajo de grado - Pregrado
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.content.spa.fl_str_mv Text
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/bachelorThesis
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/TP
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_7a1f
status_str publishedVersion
dc.identifier.uri.none.fl_str_mv https://repositorio.unicolmayor.edu.co/handle/unicolmayor/5715
url https://repositorio.unicolmayor.edu.co/handle/unicolmayor/5715
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Gudat W, Heizmann W, Hockertz S, Nolting S. Candida Albicans. Z Allgemeinmed. 1998;74(17–18):782–5
Basmaciyan L, Bon F, Paradis T, Lapaquette P, Dalle F. “Candida Albicans Interactions With The Host: Crossing The Intestinal Epithelial Barrier.” Tissue Barriers [Internet]. 2019;7(2):1–31. Available from: https://doi.org/10.1080/21688370.2019.1612661
Oberoi JK. Invasive candidiasis [Internet]. Campion EW, editor. Vol. 23, Journal International Medical Sciences Academy. 2010 [cited 2021 Feb 19]. p. 25–8. Available from: http://www.nejm.org/doi/10.1056/NEJMra1315399
Bartlett JG. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Infect Dis Clin Pract. 2004;12(6):376.
Bedout C de, Gómez BL. Candida y candidiasis invasora: un reto continuo para su diagnóstico temprano. Infectio. 2010;14(94):159–71.
Valencia A, Páez A, Sampedro M, Ávila C, Cardona J, Mesa C. Candidemia en Colombia. Biomédica. 2020;40(1):1–33.
Maestre Vera JR, Alou Cervera L. Ventajas y desventajas de los antifúngicos de uso tópico [Internet]. Vol. 14, Revista Espanola de Quimioterapia. 2001 [cited 2021 Feb 19]. p. 232–7. Available from: https://seq.es/seq/html/revista_seq/0301/rev1.html
Spampinato C, Leonardi D. Candida infections, causes, targets, and resistance mechanisms: Traditional and alternative antifungal agents. Biomed Res Int. 2013;2013.
Parente-Rocha JA, Bailão AM, Amaral AC, Taborda CP, Paccez JD, Borges CL, et al. Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi. Mediators Inflamm. 2017;2017
K. Mazu T, A. Bricker B, Flores-Rozas H, Y. Ablordeppey S. The Mechanistic Targets of Antifungal Agents: An Overview. Mini-Reviews Med Chem. 2016;16(7):555–78.
Organización Mundial de la Salud. Un informe de la OMS confirma que el mundo se está quedando sin antibióticos [Internet]. Who. 2017 [cited 2021 Feb 19]. p. 1–3. Available from: https://www.who.int/es/news/item/20-09-2017-the-world-is-runningout-of-antibiotics-who-report-confirms
Bondaryk M, Staniszewska M, Zielińska P, Urbańczyk-Lipkowska Z. Natural antimicrobial peptides as inspiration for design of a new generation antifungal compounds. Vol. 3, Journal of Fungi. 2017.
Lachowicz JI, Szczepski K, Scano A, Casu C, Fais S, Orrù G, et al. The Best Peptidomimetic Strategies to Undercover Antibacterial Peptides. Int J Mol Sci 2020, Vol 21, Page 7349 [Internet]. 2020 Oct 5 [cited 2021 Sep 15];21(19):7349. Available from: https://www.mdpi.com/1422-0067/21/19/7349/htm
Moghaddam MM, Abolhassani F, Babavalian H, Mirnejad R, Barjini KA, Amani J. Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli. Probiotics Antimicrob Proteins [Internet]. 2012 Jun 4 [cited 2021 Dec 2];4(2):133–9. Available from: https://ezproxy.unicolmayor.edu.co:2425/article/10.1007/s12602-012-9098-7
Vargas-Casanova Y, Carlos Villamil Poveda J, Jenny Rivera-Monroy Z, Ceballos Garzón A, Fierro-Medina R, Le Pape P, et al. Palindromic Peptide LfcinB (21-25)Pal Exhibited Antifungal Activity against Multidrug-Resistant Candida. ChemistrySelect. 2020;5(24):7236–42.
EL LARGO CAMINO HACIA EL ANTIFÚNGICO IDEAL [Internet]. [cited 2021 Feb 19]. Available from: https://www.siicsalud.com/des/expertoimpreso.php/99235
Wang G. Human antimicrobial peptides and proteins. Pharmaceuticals. 2014;7(5):545– 94.
Brogden NK, Brogden KA, Brogden KA. Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int J Antimicrob Agents [Internet]. 2011;38(3):217–25. Available from: http://clinicaltrials.gov/
Wakabayashi H, Matsumoto H, Hashimoto K, Teraguchi S, Takase M, Hayasawa H. N-acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activityfile:///C:/Users/mateo/Downloads/25.pdf. Antimicrob Agents Chemother. 1999;43(5):1267–9
Wakabayashi H, Matsumoto H, Hashimoto K, Teraguchi S, Takase M, Hayasawa H. N-acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activityfile:///C:/Users/mateo/Downloads/25.pdf. Antimicrob Agents Chemother. 1999;43(5):1267–9
Rodríguez-Franco DA, Vázquez-Moreno L, Ramos-Clamont Montfort G. Actividad antimicrobiana de la lactoferrina: Mecanismos y aplicaciones clínicas potenciales. Rev Latinoam Microbiol. 2005;47(3–4):102–11
Kuipers ME, De Vries HG, Eikelboom MC, Meijer DKF, Swart PJ. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob Agents Chemother. 1999;43(11):2635–41.
Fernandes KE, Weeks K, Carter DA. Lactoferrin Is Broadly Active against Yeasts and Highly Synergistic with Amphotericin B. Antimicrob Agents Chemother [Internet]. 2020 May 1 [cited 2021 Sep 15];64(5). Available from: /pmc/articles/PMC7179636/
Wakabayashi H, Abe S, Teraguchi S, Hayasawa H, Yamaguchi H. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin- related compounds. Antimicrob Agents Chemother. 1998;42(7):1587–91.
Chang C-K, Kao M-C, Lan C-Y. Antimicrobial Activity of the Peptide LfcinB15 against Candida albicans. J Fungi 2021, Vol 7, Page 519 [Internet]. 2021 Jun 29 [cited 2021 Sep 15];7(7):519. Available from: https://www.mdpi.com/2309- 608X/7/7/519/htm
Feng X, Liu C, Guo J, Song X, Li J, Xu W, et al. Recombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33. Appl Microbiol Biotechnol [Internet]. 2012 Sep 22 [cited 2021 Dec 2];95(5):1191–8. Available from: https://ezproxy.unicolmayor.edu.co:2425/article/10.1007/s00253-011- 3816-z
Xi D, Teng D, Wang X, Mao R, Yang Y, Xiang W, et al. Design, expression and characterization of the hybrid antimicrobial peptide LHP7, connected by a flexible linker, against Staphylococcus and Streptococcus. Process Biochem. 2013 Mar 1;48(3):453–61
Jang SA, Kim H, Lee JY, Shin JR, Kim DJ, Cho JH, et al. Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb. Peptides [Internet]. 2012 [cited 2021 Dec 2];34(2):283–9. Available from: https://ezproxy.unicolmayor.edu.co:2163/science/article/pii/S0196978112000368
Roshanak S, Shahidi F, Yazdi FT, Javadmanesh A, Movaffagh J. Evaluation of Antimicrobial Activity of Buforin I and Nisin and the Synergistic Effect of Their Combination as a Novel Antimicrobial Preservative. J Food Prot [Internet]. 2020 Nov 1 [cited 2021 Dec 2];83(11):2018–25. Available from: https://doi.org/10.4315/JFP-20- 127
Cho JH, Sung BH, Kim SC. Buforins: Histone H2A-derived antimicrobial peptides from toad stomach. Biochim Biophys Acta - Biomembr [Internet]. 2009;1788(8):1564– 9. Available from: http://dx.doi.org/10.1016/j.bbamem.2008.10.025
Jang WS, Kim HK, Lee KY, Kim SA, Han YS, Lee IH. Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium. FEBS Lett. 2006;580(5):1490–6
González L, Muñoz C, Celis A. Evaluación de la actividad inhibidora de los péptidos antimicrobianos Buforina II y Frenatin 2.3S ante Malassezia spp [Internet]. instname:Universidad de los Andes. Uniandes; 2019 [cited 2021 Feb 19]. Available from: https://repositorio.uniandes.edu.co/handle/1992/45818
Park CB, Yi KS, Matsuzaki K, Kim MS, Kim SC. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: The proline hinge is responsible for the cell-penetrating ability of buforin II. Proc Natl Acad Sci U S A [Internet]. 2000 Jul 18 [cited 2021 Dec 2];97(15):8245–50. Available from: /pmc/articles/PMC26932/
Huertas Méndez NDJ, Vargas Casanova Y, Gómez Chimbi AK, Hernández E, Leal Castro AL, Melo Diaz JM, et al. Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Antimicrobial Activity against E. coli ATCC 11775, S. maltophilia ATCC 13636 and S. enteritidis ATCC 13076. Molecules [Internet]. 2017 Mar 12 [cited 2021 Dec 2];22(3):452. Available from: https://www.mdpi.com/1420-3049/22/3/452/htm
Pineda-Castañeda HM, Huertas-Ortiz KA, Leal-Castro AL, Vargas-Casanova Y, ParraGiraldo CM, García-Castañeda JE, et al. Designing Chimeric Peptides: A Powerful Tool for Enhancing Antibacterial Activity. Chem Biodivers [Internet]. 2021 Feb 1 [cited 2021 Dec 2];18(2):e2000885. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/cbdv.202000885
Aguirre-guataqui K, Pineda-castañeda H, Ceballos-garzon A, Vargas-casanova Y, García-castañeda J, Parra-giraldo CM. Chimeric peptides derived from Bovine Lactoferricin and Buforin II : antifungal activity against reference strains and clin- ical isolates of Candida spp. 2021;1–16.
Liu SP, Zhou L, Lakshminarayanan R, Beuerman RW. Multivalent antimicrobial peptides as therapeutics: Design principles and structural diversities. Int J Pept Res Ther. 2010;16(3):199–213
Romo JA, Pierce CG, Esqueda M, Hung C-Y, Saville SP, Lopez-Ribot JL. In Vitro Characterization of a Biaryl Amide Anti-virulence Compound Targeting Candida albicans Filamentation and Biofilm Formation. Front Cell Infect Microbiol [Internet]. 2018 Jul 10 [cited 2021 Sep 15];8(JUL). Available from: /pmc/articles/PMC6048184/
Chow EWL, Pang LM, Wang Y. From Jekyll to Hyde: The Yeast–Hyphal Transition of Candida albicans. Pathog 2021, Vol 10, Page 859 [Internet]. 2021 Jul 7 [cited 2021 Sep 15];10(7):859. Available from: https://www.mdpi.com/2076-0817/10/7/859/htm
C d’Enfert. Hidden killers: persistence of opportunistic fungal pathogens in the human host. Curr Opin Microbiol [Internet]. 2009 Aug [cited 2021 Sep 15];12(4):358–64. Available from: https://pubmed.ncbi.nlm.nih.gov/19541532/
S H, S M, B H. Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota. J Microbiol [Internet]. 2016 Mar 1 [cited 2021 Sep 15];54(3):149–69. Available from: https://pubmed.ncbi.nlm.nih.gov/26920876/
Garcia-Rubio R, de Oliveira HC, Rivera J, Trevijano-Contador N. The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species. Front Microbiol. 2020 Jan 9;0:2993
C d’Enfert, AK K, LR A, S C, N C, M D, et al. The impact of the Fungus-HostMicrobiota interplay upon Candida albicans infections: current knowledge and new perspectives. FEMS Microbiol Rev [Internet]. 2021 [cited 2021 Sep 15];45(3). Available from: https://pubmed.ncbi.nlm.nih.gov/33232448/
LN M, IM van der H, SF C, AP S, RA S, S G, et al. Candida colonisation as a source for candidaemia. J Hosp Infect [Internet]. 2009 [cited 2021 Sep 15];72(1):9–16. Available from: https://pubmed.ncbi.nlm.nih.gov/19303662/
J T, M J, T M, E P, S B, I K, et al. Candida albicans- The Virulence Factors and Clinical Manifestations of Infection. J fungi (Basel, Switzerland) [Internet]. 2021 Feb 1 [cited 2021 Sep 15];7(2):1–19. Available from: https://pubmed.ncbi.nlm.nih.gov/33499276/
Pereira R, Fontenelle RO dos S, Brito EHS de, Morais SM de. Biofilm of Candida albicans: formation, regulation and resistance. J Appl Microbiol [Internet]. 2021 Jul 1 [cited 2021 Sep 15];131(1):11–22. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/jam.14949
Factores de virulencia para la infección de tejidos queratinizados por Candida albicans y hongos dermatofitos [Internet]. [cited 2021 Sep 15]. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120- 87052012000100005
Lohse MB, Gulati M, Johnson AD, Nobile CJ. Development and regulation of singleand multi-species Candida albicans biofilms. Nat Rev Microbiol 2017 161 [Internet]. 2017 Oct 3 [cited 2021 Sep 15];16(1):19–31. Available from: https://www.nature.com/articles/nrmicro.2017.107
Martins N, Ferreira ICFR, Barros L, Silva S, Henriques M. Candidiasis: Predisposing Factors, Prevention, Diagnosis and Alternative Treatment. Mycopathol 2014 1775 [Internet]. 2014 May 1 [cited 2021 Sep 15];177(5):223–40. Available from: https://link.springer.com/article/10.1007/s11046-014-9749-1
Wall G, Montelongo-Jauregui D, Vidal Bonifacio B, Lopez-Ribot JL, Uppuluri P. Candida albicans biofilm growth and dispersal: contributions to pathogenesis. Curr Opin Microbiol. 2019 Dec 1;52:1–6
Rivera-Toledo E, Uriel Jiménez-Delgadillo A, Manzano-Gayosso P, para correspondencia A, Rivera Toledo E. Antifúngicos poliénicos. Mecanismo de acción y aplicaciones. 2020 [cited 2021 Sep 15];63. Available from: http://doi.org/10.22201/fm.24484865e.2020.63.2.02
Cortés L JA, Russi N JA. Equinocandinas. Rev Chil infectología [Internet]. 2011 Dec [cited 2021 Sep 15];28(6):529–36. Available from: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716- 10182011000700004&lng=es&nrm=iso&tlng=es
Cervera C. Candidemia y candidiasis invasora en el adulto. Formas clínicas y tratamiento. Enferm Infecc Microbiol Clin. 2012 Oct 1;30(8):483–91.
Carolus H, Pierson S, Lagrou K, Dijck P Van. Amphotericin B and Other Polyenes— Discovery, Clinical Use, Mode of Action and Drug Resistance. J Fungi [Internet]. 2020 Dec 1 [cited 2021 Sep 15];6(4):1–20. Available from: /pmc/articles/PMC7724567/
Fattouh N, Hdayed D, Geukgeuzian G, Tokajian S, Khalaf RA. Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates. Fungal Genet Biol. 2021 Aug 1;153:103575.
Garcia-Effron G, Park S, Perlin DS. Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints. Antimicrob Agents Chemother [Internet]. 2009 Jan [cited 2021 Sep 15];53(1):112. Available from: /pmc/articles/PMC2612148/
Shwaiki LN, Lynch KM, Arendt EK. Future of antimicrobial peptides derived from plants in food application – A focus on synthetic peptides. Trends Food Sci Technol. 2021 Jun 1;112:312–24
Alberto Téllez G, Castaño JC. Péptidos antimicrobianos Antimicrobial peptides. 2010 [cited 2021 Sep 15];14(1):55–67. Available from: www.ncbi.nlm.nih.gov/pubmed
Mwangi J, Hao X, Lai R, Zhang ZY. Antimicrobial peptides: new hope in the war against multidrug resistance. Zool Res. 2019;40(6):488–505.
Lima PG, Oliveira JTA, Amaral JL, Freitas CDT, Souza PFN. Synthetic antimicrobial peptides: Characteristics, design, and potential as alternative molecules to overcome microbial resistance. Life Sci. 2021 Aug 1;278:119647
Agüero E, Quijada P, García-Novo MD. Adición de lactoferrina a las fórmulas de inicio. An Pediatría Contin [Internet]. 2008 Apr 1 [cited 2022 Jan 30];6(2):103–7. Available from: https://www.elsevier.es/es-revista-anales-pediatria-continuada-51- articulo-adicion-lactoferrina-formulas-inicio-S1696281808748613
Mexicana AF, México AC, Serrano D, Elisa M. 3, julio-septiembre. Rev Mex Ciencias Farm [Internet]. 2007 [cited 2022 Jan 30];38:30–8. Available from: http://www.redalyc.org/articulo.oa?id=57938306
Zhang T, Yang W, Liu N. Effect of loop structure of bovine lactoferricin on apoptosis in Jurkat cells. BioMetals 2010 233 [Internet]. 2010 Mar 17 [cited 2021 Sep 16];23(3):555–61. Available from: https://link.springer.com/article/10.1007/s10534- 010-9324-2
Wang L, Wang YL, Lv ZL, Zhang E peng, Guo A zhen. Design of bovine lactoferricinderived peptide and its expression and activity in Pichia pastoris. Biochem Biophys Res Commun. 2021 Jan 1;534:822–9.
Farnaud S, Evans RW. Lactoferrin—a multifunctional protein with antimicrobial properties. Mol Immunol. 2003 Nov 1;40(7):395–405.
Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: A lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties [Internet]. Vol. 62, Cellular and Molecular Life Sciences. Cell Mol Life Sci; 2005 [cited 2021 Sep 16]. p. 2588–98. Available from: https://pubmed.ncbi.nlm.nih.gov/16261252/
Huertas N de J, Monroy ZJR, Medina RF, Castañeda JEG. Antimicrobial Activity of Truncated and Polyvalent Peptides Derived from the FKCRRWQWRMKKGLA Sequence against Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923. Mol A J Synth Chem Nat Prod Chem [Internet]. 2017 Jun 14 [cited 2021 Sep 16];22(6). Available from: /pmc/articles/PMC6152618/
Roshanak S, Shahidi F, Tabatabaei Yazdi F, Javadmanesh A, Movaffagh J. Buforin I an alternative to conventional antibiotics: Evaluation of the antimicrobial properties, stability, and safety. Microb Pathog [Internet]. 2021 Dec 1 [cited 2021 Dec 2];161:105301. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0882401021005751
Park CB, Kim MS, Kim SC. A novel antimicrobial peptide from Bufo bufo gargarizans. Biochem Biophys Res Commun. 1996 Jan 5;218(1):408–13.
Park CB, Kim HS, Kim SC. Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun. 1998 Mar 6;244(1):253–7.
Pavia KE, Spinella SA, Elmore DE. Novel Histone-Derived Antimicrobial Peptides Use Different Antimicrobial Mechanisms. Biochim Biophys Acta [Internet]. 2012 Mar [cited 2021 Dec 2];1818(3):869. Available from: /pmc/articles/PMC3273674
Castañeda HM. Péptidos Quiméricos Derivados De La Lactoferricina Bovina Y La Buforina: Síntesis, Caracterización Y Evaluación De Su Actividad Antibacteriana. Tesis Maest [Internet]. 2019 [cited 2021 Dec 2];34. Available from: https://repositorio.unal.edu.co/handle/unal/76691
Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Ninth Edition. [Internet]. CLSI document M07-A9(2012.). [cited 2021 Sep 16]. Available from: https://clsi.org/media/1928/m07ed11_sample.pdf
M26-A Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline This document provides procedures for determining the lethal activity of antimicrobial agents. 1999 [cited 2021 Sep 16]; Available from: www.clsi.org.
Solarte VA, Rosas JE, Rivera ZJ, Arango-Rodríguez ML, García JE, Vernot JP. A tetrameric peptide derived from bovine lactoferricin exhibits specific cytotoxic effects against oral squamous-cell carcinoma cell lines. Biomed Res Int [Internet]. 2015;2015. Available from: http://dx.doi.org/10.1155/2015/630179
Ježíková Z, Pagáč T, Víglaš J, Pfeiferová B, Šoltys K, Bujdáková H, et al. Synergy Over Monotherapy. Curr Microbiol [Internet]. 2019 Apr 2 [cited 2022 Feb 16];76(6):673–7. Available from: https://link.springer.com/article/10.1007/s00284-019- 01678-9
Wei G-X, Campagna AN, Bobek LA. Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide. Ann Clin Microbiol Antimicrob 2007 61 [Internet]. 2007 Nov 11 [cited 2021 Sep 16];6(1):1–10. Available from: https://annclinmicrob.biomedcentral.com/articles/10.1186/1476-0711-6-14
Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical Microbiology E, Diseases I. Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin Microbiol Infect [Internet]. 2000 Sep 1 [cited 2022 Jan 21];6(9):503–8. Available from:
Lakshminarayanan R, Liu S, Li J, Nandhakumar M, Aung TT, Goh E, et al. Synthetic Multivalent Antifungal Peptides Effective against Fungi. PLoS One [Internet]. 2014 Feb 3 [cited 2022 Feb 24];9(2):87730. Available from: /pmc/articles/PMC3912015/
Yang C, Guo S, Wu X, Yang P, Han L, Dai X, et al. Multiscale study on the enhancing effect and mechanism of borneolum on transdermal permeation of drugs with different log P values and molecular sizes. Int J Pharm. 2020 Apr 30;580:119225.
Klubthawee N, Adisakwattana P, Hanpithakpong W, Somsri S, Aunpad R. A novel, rationally designed, hybrid antimicrobial peptide, inspired by cathelicidin and aurein, exhibits membrane-active mechanisms against Pseudomonas aeruginosa. Sci Rep [Internet]. 2020;10(1). Available from: www.nature.com/scientificreports
Arfa A Ben, Combes S, Preziosi-Belloy L, Gontard N, Chalier P. Antimicrobial activity of carvacrol related to its chemical structure.
Wade HM, Darling LEO, Elmore DE. Hybrids Made from Antimicrobial Peptides with Different Mechanisms of Action Show Enhanced Membrane Permeabilization. Biochim Biophys acta Biomembr [Internet]. 2019 Oct 1 [cited 2022 Jan 21];1861(10):182980. Available from: /pmc/articles/PMC6721965/
Wade HM, Darling LEO, Elmore DE. Hybrids Made from Antimicrobial Peptides with Different Mechanisms of Action Show Enhanced Membrane Permeabilization. Biochim Biophys acta Biomembr [Internet]. 2019 Oct 1 [cited 2022 Jan 21];1861(10):182980. Available from: /pmc/articles/PMC6721965/
Pineda HM. PÉPTIDOS QUIMÉRICOS DERIVADOS DE LA LACTOFERRICINA BOVINA Y LA BUFORINA: SÍNTESIS, CARACTERIZACIÓN Y EVALUACIÓN DE SU ACTIVIDAD ANTIBACTERIANA. 2019;
Vega Chaparro SC, Valencia Salguero JT, Martínez Baquero DA, Rosas Pérez JE. Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens. Biomed Res Int [Internet]. 2018 [cited 2022 Jan 21];2018. Available from: /pmc/articles/PMC6015718/
Lai YW, Campbell LT, Wilkins MR, Pang CNI, Chen S, Carter DA. Synergy and antagonism between iron chelators and antifungal drugs in Cryptococcus. Int J Antimicrob Agents. 2016 Oct 1;48(4):388–94.
dc.rights.eng.fl_str_mv Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2022
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/closedAccess
dc.rights.creativecommons.spa.fl_str_mv Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_14cb
rights_invalid_str_mv Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2022
https://creativecommons.org/licenses/by-nc-sa/4.0/
Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
http://purl.org/coar/access_right/c_14cb
eu_rights_str_mv closedAccess
dc.format.extent.spa.fl_str_mv 66p.
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.faculty.spa.fl_str_mv Facultad de Ciencias de la Salud
dc.publisher.place.spa.fl_str_mv Bogotá
dc.publisher.program.spa.fl_str_mv Bacteriología y Laboratorio Clínico
institution Colegio Mayor de Cundinamarca
bitstream.url.fl_str_mv https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/5/license.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/6/Evaluaci%c3%b3n%20de%20la%20actividad%20anti-Candida%20de%20p%c3%a9ptidos%20quim%c3%a9ricos%20ramificados%20derivados%20de%20Lactoferricina%20Bov%5bMateo%5d%20%281%29.pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/8/presentacion%20trabajo%20de%20grado%202.pptx.pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/10/FORMATO%20IDENTIFICACI%c3%93N%20TRABAJOS%20DE%20GRADO%20MATEO%20MARQUEZ-FIRMADO.pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/12/CARTA%20DERECHOS%20DE%20AUTOR%20Marquez.pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/7/Evaluaci%c3%b3n%20de%20la%20actividad%20anti-Candida%20de%20p%c3%a9ptidos%20quim%c3%a9ricos%20ramificados%20derivados%20de%20Lactoferricina%20Bov%5bMateo%5d%20%281%29.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/9/presentacion%20trabajo%20de%20grado%202.pptx.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/11/FORMATO%20IDENTIFICACI%c3%93N%20TRABAJOS%20DE%20GRADO%20MATEO%20MARQUEZ-FIRMADO.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/13/CARTA%20DERECHOS%20DE%20AUTOR%20Marquez.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/14/Evaluaci%c3%b3n%20de%20la%20actividad%20anti-Candida%20de%20p%c3%a9ptidos%20quim%c3%a9ricos%20ramificados%20derivados%20de%20Lactoferricina%20Bov%5bMateo%5d%20%281%29.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/15/presentacion%20trabajo%20de%20grado%202.pptx.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/16/CARTA%20DERECHOS%20DE%20AUTOR%20Marquez.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/17/FORMATO%20IDENTIFICACI%c3%93N%20TRABAJOS%20DE%20GRADO%20MATEO%20MARQUEZ-FIRMADO.pdf
bitstream.checksum.fl_str_mv 2f9959eaf5b71fae44bbf9ec84150c7a
4e7a94a34caa1d7390bfc54225099a3c
882f44b3e9e294627f1ac08b059f4339
ccae006dc3d4be181d0e244d996aadcf
168374500082517f2356b8ae3d4a9f59
e4a7f45db4818edfb1aa57b8e497188c
105e1959755d7bb68cc2c107cd37f4d3
179a3cea852b96ddd491eee59d563bd8
b95e76cb36aa6fcefebb96d741e327b8
812ae1d1bca7f1bc1ca79b6fd1e027bc
dff1a2608ef0d538d6a06f6234c16bda
60e3bd5d73d10d993bfb874db2e300be
d0f6a4f88aba8b1af7d6651bda1e00c0
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital Unicolmayor
repository.mail.fl_str_mv repositorio@unicolmayor.edu.co
_version_ 1812210086543622144
spelling Estupiñán Torres., Sandra Mónicabb32cb3a54f98ed0d35c5c1243907a5fParra GiraldoClaudia Marcela, Claudia Marcela5f1342ce86bcefac5efe990834ece529Vargas Casanova, Yerly62ca6840539d58ad6f6a0751720d80f3600Márquez Torres, Mateodca117e459df68c12e01763aff18842e2022-10-18T16:26:24Z2022-10-18T16:26:24Z2022https://repositorio.unicolmayor.edu.co/handle/unicolmayor/5715Los péptidos antimicrobianos (PAMs) se han considerado como una estrategia de tratamiento antimicótica prometedora, ya que cuentan con baja capacidad para inducir resistencia, poseen varios mecanismos de acción, son de amplio espectro y su combinación con antifúngicos convencionales puede generar efecto sinérgico, sin embargo, como desventajas se encuentra altos costos de producción, fácil degradación proteolítica, toxicidad en células eucariotas y hemólisis sobre los glóbulos rojos. La Lactoferricina Bovina (LfcinB) es un PAM generado tras la hidrólisis proteica de Lactoferrina Bovina (LFB), por su parte la Buforina II (BFII) es un PAM aislado del estómago del sapo Bufo bufo gargarizans. Los péptidos mencionados anteriormente se les ha atribuido un gran potencial antimicrobiano. Con la finalidad de potenciar la actividad antifúngica, se diseñaron y sintetizaron quimeras ramificadas que contienen los motivos mínimos de ambos péptidos (LfcinB: RRWQWR y BFII: RLLR), además se evaluó su actividad hemolítica y el efecto de combinar estas quimeras con fluconazol. Como resultados se obtuvo que el péptido (RRWQWR)2KXRLLRRLLR presentó mayor actividad antifúngica (Concentración mínima inhibitoria y fungicida) CMI/CMF 50 µg/mL (15.27 µM)) en comparación con la quimera (RRWQWR)2KXRLLR (CMI/CMF de 100 µg/mL (36.56 µM) contra C. albicans sensible y resistente a fluconazol. La quimera (RRWQWR)2KXRLLR no exhibió actividad hemolítica mientras que (RRWQWR)2KXRLLRRLLR presentó porcentaje de hemólisis de 11.56% a la concentración de la CMI. Con respecto a la combinación de los péptidos quiméricos ramificados junto con fluconazol, se obtuvo sinergia con ambos péptidos cuando se evaluaron frente a C. albicans sensible a este antifúngicoTabla de contenido Pág. 1. INTRODUCCIÓN.2 2. ANTECEDENTES 5 3. MARCO TEÓRICO.10 3.1 Generalidades Candida albicans..10 3.1.1 Patogenia.10 3.1.2 Manifestaciones clínicas ..12 3.1.3 Antifúngicos para Candidiasis invasiva..12 3.1.4 Mecanismos de resistencia a antifúngicos.12 3.2 Péptidos antimicrobianos.13 3.3 Lactoferrina Bovina .14 3.3 Lactoferricina Bovina.14 3.5 Buforina I.16 3.6 Buforina II16 4. OBJETIVOS ..18 4.1 Objetivo general..18 4.2 Objetivos específicos.18 5. DISEÑO METODOLÓGICO .19 5.1. Materiales19 5.1.1 Candida albicans SC5314 (Robin) Berkhout (ATCC® MYA- 2876™)19 5.1.2 Candida albicans 256 HUSI-PUJ 20 3.2 Hipótesis21 5.2. Estrategia de trabajo 21 5.3.1 Síntesis y caracterización de los péptidos22 5.3.2 Determinación de la Concentración Mínima Inhibitoria ..22 5.3.3 Concentración Mínima Fungicida23 5.3.4 Curvas de letalidad .24 5.3.5 Determinación de la actividad hemolítica .24 5.3.6 Ensayo de titulación en tablero de ajedrez25 6. RESULTADOS Y DISCUSIÓN ..27 6.1 Etapa 1: Microdilución en caldo y CMF27 6.2 Etapa 2: Cinética de actividad de péptidos quiméricos ramificados ..30 6.3 Etapa 3: Efecto hemolítico de los péptidos quiméricos ramificados34 6.4 Efecto combinado de los péptidos quiméricos ramificados mezclados con fluconazol..37 7. CONCLUSIONES .40 6. Referencias Bibliográficas41 Anexos50 Anexo 1. CMI y CMF50 Anexo 2. Actividad hemolítica. .52 Anexo 3. Titulación en tablero de ajedrez 53PregradoBacteriólogo(a) y Laboratorista Clínico66p.application/pdfspaDerechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2022https://creativecommons.org/licenses/by-nc-sa/4.0/info:eu-repo/semantics/closedAccessAtribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)http://purl.org/coar/access_right/c_14cbEvaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bovina y Buforina II.Trabajo de grado - Pregradohttp://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/version/c_970fb48d4fbd8a85Textinfo:eu-repo/semantics/bachelorThesishttps://purl.org/redcol/resource_type/TPinfo:eu-repo/semantics/publishedVersionFacultad de Ciencias de la SaludBogotáBacteriología y Laboratorio ClínicoGudat W, Heizmann W, Hockertz S, Nolting S. Candida Albicans. Z Allgemeinmed. 1998;74(17–18):782–5Basmaciyan L, Bon F, Paradis T, Lapaquette P, Dalle F. “Candida Albicans Interactions With The Host: Crossing The Intestinal Epithelial Barrier.” Tissue Barriers [Internet]. 2019;7(2):1–31. Available from: https://doi.org/10.1080/21688370.2019.1612661Oberoi JK. Invasive candidiasis [Internet]. Campion EW, editor. Vol. 23, Journal International Medical Sciences Academy. 2010 [cited 2021 Feb 19]. p. 25–8. Available from: http://www.nejm.org/doi/10.1056/NEJMra1315399Bartlett JG. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Infect Dis Clin Pract. 2004;12(6):376.Bedout C de, Gómez BL. Candida y candidiasis invasora: un reto continuo para su diagnóstico temprano. Infectio. 2010;14(94):159–71.Valencia A, Páez A, Sampedro M, Ávila C, Cardona J, Mesa C. Candidemia en Colombia. Biomédica. 2020;40(1):1–33.Maestre Vera JR, Alou Cervera L. Ventajas y desventajas de los antifúngicos de uso tópico [Internet]. Vol. 14, Revista Espanola de Quimioterapia. 2001 [cited 2021 Feb 19]. p. 232–7. Available from: https://seq.es/seq/html/revista_seq/0301/rev1.htmlSpampinato C, Leonardi D. Candida infections, causes, targets, and resistance mechanisms: Traditional and alternative antifungal agents. Biomed Res Int. 2013;2013.Parente-Rocha JA, Bailão AM, Amaral AC, Taborda CP, Paccez JD, Borges CL, et al. Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi. Mediators Inflamm. 2017;2017K. Mazu T, A. Bricker B, Flores-Rozas H, Y. Ablordeppey S. The Mechanistic Targets of Antifungal Agents: An Overview. Mini-Reviews Med Chem. 2016;16(7):555–78.Organización Mundial de la Salud. Un informe de la OMS confirma que el mundo se está quedando sin antibióticos [Internet]. Who. 2017 [cited 2021 Feb 19]. p. 1–3. Available from: https://www.who.int/es/news/item/20-09-2017-the-world-is-runningout-of-antibiotics-who-report-confirmsBondaryk M, Staniszewska M, Zielińska P, Urbańczyk-Lipkowska Z. Natural antimicrobial peptides as inspiration for design of a new generation antifungal compounds. Vol. 3, Journal of Fungi. 2017.Lachowicz JI, Szczepski K, Scano A, Casu C, Fais S, Orrù G, et al. The Best Peptidomimetic Strategies to Undercover Antibacterial Peptides. Int J Mol Sci 2020, Vol 21, Page 7349 [Internet]. 2020 Oct 5 [cited 2021 Sep 15];21(19):7349. Available from: https://www.mdpi.com/1422-0067/21/19/7349/htmMoghaddam MM, Abolhassani F, Babavalian H, Mirnejad R, Barjini KA, Amani J. Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli. Probiotics Antimicrob Proteins [Internet]. 2012 Jun 4 [cited 2021 Dec 2];4(2):133–9. Available from: https://ezproxy.unicolmayor.edu.co:2425/article/10.1007/s12602-012-9098-7Vargas-Casanova Y, Carlos Villamil Poveda J, Jenny Rivera-Monroy Z, Ceballos Garzón A, Fierro-Medina R, Le Pape P, et al. Palindromic Peptide LfcinB (21-25)Pal Exhibited Antifungal Activity against Multidrug-Resistant Candida. ChemistrySelect. 2020;5(24):7236–42.EL LARGO CAMINO HACIA EL ANTIFÚNGICO IDEAL [Internet]. [cited 2021 Feb 19]. Available from: https://www.siicsalud.com/des/expertoimpreso.php/99235Wang G. Human antimicrobial peptides and proteins. Pharmaceuticals. 2014;7(5):545– 94.Brogden NK, Brogden KA, Brogden KA. Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int J Antimicrob Agents [Internet]. 2011;38(3):217–25. Available from: http://clinicaltrials.gov/Wakabayashi H, Matsumoto H, Hashimoto K, Teraguchi S, Takase M, Hayasawa H. N-acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activityfile:///C:/Users/mateo/Downloads/25.pdf. Antimicrob Agents Chemother. 1999;43(5):1267–9Wakabayashi H, Matsumoto H, Hashimoto K, Teraguchi S, Takase M, Hayasawa H. N-acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activityfile:///C:/Users/mateo/Downloads/25.pdf. Antimicrob Agents Chemother. 1999;43(5):1267–9Rodríguez-Franco DA, Vázquez-Moreno L, Ramos-Clamont Montfort G. Actividad antimicrobiana de la lactoferrina: Mecanismos y aplicaciones clínicas potenciales. Rev Latinoam Microbiol. 2005;47(3–4):102–11Kuipers ME, De Vries HG, Eikelboom MC, Meijer DKF, Swart PJ. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob Agents Chemother. 1999;43(11):2635–41.Fernandes KE, Weeks K, Carter DA. Lactoferrin Is Broadly Active against Yeasts and Highly Synergistic with Amphotericin B. Antimicrob Agents Chemother [Internet]. 2020 May 1 [cited 2021 Sep 15];64(5). Available from: /pmc/articles/PMC7179636/Wakabayashi H, Abe S, Teraguchi S, Hayasawa H, Yamaguchi H. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin- related compounds. Antimicrob Agents Chemother. 1998;42(7):1587–91.Chang C-K, Kao M-C, Lan C-Y. Antimicrobial Activity of the Peptide LfcinB15 against Candida albicans. J Fungi 2021, Vol 7, Page 519 [Internet]. 2021 Jun 29 [cited 2021 Sep 15];7(7):519. Available from: https://www.mdpi.com/2309- 608X/7/7/519/htmFeng X, Liu C, Guo J, Song X, Li J, Xu W, et al. Recombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33. Appl Microbiol Biotechnol [Internet]. 2012 Sep 22 [cited 2021 Dec 2];95(5):1191–8. Available from: https://ezproxy.unicolmayor.edu.co:2425/article/10.1007/s00253-011- 3816-zXi D, Teng D, Wang X, Mao R, Yang Y, Xiang W, et al. Design, expression and characterization of the hybrid antimicrobial peptide LHP7, connected by a flexible linker, against Staphylococcus and Streptococcus. Process Biochem. 2013 Mar 1;48(3):453–61Jang SA, Kim H, Lee JY, Shin JR, Kim DJ, Cho JH, et al. Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb. Peptides [Internet]. 2012 [cited 2021 Dec 2];34(2):283–9. Available from: https://ezproxy.unicolmayor.edu.co:2163/science/article/pii/S0196978112000368Roshanak S, Shahidi F, Yazdi FT, Javadmanesh A, Movaffagh J. Evaluation of Antimicrobial Activity of Buforin I and Nisin and the Synergistic Effect of Their Combination as a Novel Antimicrobial Preservative. J Food Prot [Internet]. 2020 Nov 1 [cited 2021 Dec 2];83(11):2018–25. Available from: https://doi.org/10.4315/JFP-20- 127Cho JH, Sung BH, Kim SC. Buforins: Histone H2A-derived antimicrobial peptides from toad stomach. Biochim Biophys Acta - Biomembr [Internet]. 2009;1788(8):1564– 9. Available from: http://dx.doi.org/10.1016/j.bbamem.2008.10.025Jang WS, Kim HK, Lee KY, Kim SA, Han YS, Lee IH. Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium. FEBS Lett. 2006;580(5):1490–6González L, Muñoz C, Celis A. Evaluación de la actividad inhibidora de los péptidos antimicrobianos Buforina II y Frenatin 2.3S ante Malassezia spp [Internet]. instname:Universidad de los Andes. Uniandes; 2019 [cited 2021 Feb 19]. Available from: https://repositorio.uniandes.edu.co/handle/1992/45818Park CB, Yi KS, Matsuzaki K, Kim MS, Kim SC. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: The proline hinge is responsible for the cell-penetrating ability of buforin II. Proc Natl Acad Sci U S A [Internet]. 2000 Jul 18 [cited 2021 Dec 2];97(15):8245–50. Available from: /pmc/articles/PMC26932/Huertas Méndez NDJ, Vargas Casanova Y, Gómez Chimbi AK, Hernández E, Leal Castro AL, Melo Diaz JM, et al. Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Antimicrobial Activity against E. coli ATCC 11775, S. maltophilia ATCC 13636 and S. enteritidis ATCC 13076. Molecules [Internet]. 2017 Mar 12 [cited 2021 Dec 2];22(3):452. Available from: https://www.mdpi.com/1420-3049/22/3/452/htmPineda-Castañeda HM, Huertas-Ortiz KA, Leal-Castro AL, Vargas-Casanova Y, ParraGiraldo CM, García-Castañeda JE, et al. Designing Chimeric Peptides: A Powerful Tool for Enhancing Antibacterial Activity. Chem Biodivers [Internet]. 2021 Feb 1 [cited 2021 Dec 2];18(2):e2000885. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/cbdv.202000885Aguirre-guataqui K, Pineda-castañeda H, Ceballos-garzon A, Vargas-casanova Y, García-castañeda J, Parra-giraldo CM. Chimeric peptides derived from Bovine Lactoferricin and Buforin II : antifungal activity against reference strains and clin- ical isolates of Candida spp. 2021;1–16.Liu SP, Zhou L, Lakshminarayanan R, Beuerman RW. Multivalent antimicrobial peptides as therapeutics: Design principles and structural diversities. Int J Pept Res Ther. 2010;16(3):199–213Romo JA, Pierce CG, Esqueda M, Hung C-Y, Saville SP, Lopez-Ribot JL. In Vitro Characterization of a Biaryl Amide Anti-virulence Compound Targeting Candida albicans Filamentation and Biofilm Formation. Front Cell Infect Microbiol [Internet]. 2018 Jul 10 [cited 2021 Sep 15];8(JUL). Available from: /pmc/articles/PMC6048184/Chow EWL, Pang LM, Wang Y. From Jekyll to Hyde: The Yeast–Hyphal Transition of Candida albicans. Pathog 2021, Vol 10, Page 859 [Internet]. 2021 Jul 7 [cited 2021 Sep 15];10(7):859. Available from: https://www.mdpi.com/2076-0817/10/7/859/htmC d’Enfert. Hidden killers: persistence of opportunistic fungal pathogens in the human host. Curr Opin Microbiol [Internet]. 2009 Aug [cited 2021 Sep 15];12(4):358–64. Available from: https://pubmed.ncbi.nlm.nih.gov/19541532/S H, S M, B H. Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota. J Microbiol [Internet]. 2016 Mar 1 [cited 2021 Sep 15];54(3):149–69. Available from: https://pubmed.ncbi.nlm.nih.gov/26920876/Garcia-Rubio R, de Oliveira HC, Rivera J, Trevijano-Contador N. The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species. Front Microbiol. 2020 Jan 9;0:2993C d’Enfert, AK K, LR A, S C, N C, M D, et al. The impact of the Fungus-HostMicrobiota interplay upon Candida albicans infections: current knowledge and new perspectives. FEMS Microbiol Rev [Internet]. 2021 [cited 2021 Sep 15];45(3). Available from: https://pubmed.ncbi.nlm.nih.gov/33232448/LN M, IM van der H, SF C, AP S, RA S, S G, et al. Candida colonisation as a source for candidaemia. J Hosp Infect [Internet]. 2009 [cited 2021 Sep 15];72(1):9–16. Available from: https://pubmed.ncbi.nlm.nih.gov/19303662/J T, M J, T M, E P, S B, I K, et al. Candida albicans- The Virulence Factors and Clinical Manifestations of Infection. J fungi (Basel, Switzerland) [Internet]. 2021 Feb 1 [cited 2021 Sep 15];7(2):1–19. Available from: https://pubmed.ncbi.nlm.nih.gov/33499276/Pereira R, Fontenelle RO dos S, Brito EHS de, Morais SM de. Biofilm of Candida albicans: formation, regulation and resistance. J Appl Microbiol [Internet]. 2021 Jul 1 [cited 2021 Sep 15];131(1):11–22. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/jam.14949Factores de virulencia para la infección de tejidos queratinizados por Candida albicans y hongos dermatofitos [Internet]. [cited 2021 Sep 15]. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120- 87052012000100005Lohse MB, Gulati M, Johnson AD, Nobile CJ. Development and regulation of singleand multi-species Candida albicans biofilms. Nat Rev Microbiol 2017 161 [Internet]. 2017 Oct 3 [cited 2021 Sep 15];16(1):19–31. Available from: https://www.nature.com/articles/nrmicro.2017.107Martins N, Ferreira ICFR, Barros L, Silva S, Henriques M. Candidiasis: Predisposing Factors, Prevention, Diagnosis and Alternative Treatment. Mycopathol 2014 1775 [Internet]. 2014 May 1 [cited 2021 Sep 15];177(5):223–40. Available from: https://link.springer.com/article/10.1007/s11046-014-9749-1Wall G, Montelongo-Jauregui D, Vidal Bonifacio B, Lopez-Ribot JL, Uppuluri P. Candida albicans biofilm growth and dispersal: contributions to pathogenesis. Curr Opin Microbiol. 2019 Dec 1;52:1–6Rivera-Toledo E, Uriel Jiménez-Delgadillo A, Manzano-Gayosso P, para correspondencia A, Rivera Toledo E. Antifúngicos poliénicos. Mecanismo de acción y aplicaciones. 2020 [cited 2021 Sep 15];63. Available from: http://doi.org/10.22201/fm.24484865e.2020.63.2.02Cortés L JA, Russi N JA. Equinocandinas. Rev Chil infectología [Internet]. 2011 Dec [cited 2021 Sep 15];28(6):529–36. Available from: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716- 10182011000700004&lng=es&nrm=iso&tlng=esCervera C. Candidemia y candidiasis invasora en el adulto. Formas clínicas y tratamiento. Enferm Infecc Microbiol Clin. 2012 Oct 1;30(8):483–91.Carolus H, Pierson S, Lagrou K, Dijck P Van. Amphotericin B and Other Polyenes— Discovery, Clinical Use, Mode of Action and Drug Resistance. J Fungi [Internet]. 2020 Dec 1 [cited 2021 Sep 15];6(4):1–20. Available from: /pmc/articles/PMC7724567/Fattouh N, Hdayed D, Geukgeuzian G, Tokajian S, Khalaf RA. Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates. Fungal Genet Biol. 2021 Aug 1;153:103575.Garcia-Effron G, Park S, Perlin DS. Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints. Antimicrob Agents Chemother [Internet]. 2009 Jan [cited 2021 Sep 15];53(1):112. Available from: /pmc/articles/PMC2612148/Shwaiki LN, Lynch KM, Arendt EK. Future of antimicrobial peptides derived from plants in food application – A focus on synthetic peptides. Trends Food Sci Technol. 2021 Jun 1;112:312–24Alberto Téllez G, Castaño JC. Péptidos antimicrobianos Antimicrobial peptides. 2010 [cited 2021 Sep 15];14(1):55–67. Available from: www.ncbi.nlm.nih.gov/pubmedMwangi J, Hao X, Lai R, Zhang ZY. Antimicrobial peptides: new hope in the war against multidrug resistance. Zool Res. 2019;40(6):488–505.Lima PG, Oliveira JTA, Amaral JL, Freitas CDT, Souza PFN. Synthetic antimicrobial peptides: Characteristics, design, and potential as alternative molecules to overcome microbial resistance. Life Sci. 2021 Aug 1;278:119647Agüero E, Quijada P, García-Novo MD. Adición de lactoferrina a las fórmulas de inicio. An Pediatría Contin [Internet]. 2008 Apr 1 [cited 2022 Jan 30];6(2):103–7. Available from: https://www.elsevier.es/es-revista-anales-pediatria-continuada-51- articulo-adicion-lactoferrina-formulas-inicio-S1696281808748613Mexicana AF, México AC, Serrano D, Elisa M. 3, julio-septiembre. Rev Mex Ciencias Farm [Internet]. 2007 [cited 2022 Jan 30];38:30–8. Available from: http://www.redalyc.org/articulo.oa?id=57938306Zhang T, Yang W, Liu N. Effect of loop structure of bovine lactoferricin on apoptosis in Jurkat cells. BioMetals 2010 233 [Internet]. 2010 Mar 17 [cited 2021 Sep 16];23(3):555–61. Available from: https://link.springer.com/article/10.1007/s10534- 010-9324-2Wang L, Wang YL, Lv ZL, Zhang E peng, Guo A zhen. Design of bovine lactoferricinderived peptide and its expression and activity in Pichia pastoris. Biochem Biophys Res Commun. 2021 Jan 1;534:822–9.Farnaud S, Evans RW. Lactoferrin—a multifunctional protein with antimicrobial properties. Mol Immunol. 2003 Nov 1;40(7):395–405.Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: A lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties [Internet]. Vol. 62, Cellular and Molecular Life Sciences. Cell Mol Life Sci; 2005 [cited 2021 Sep 16]. p. 2588–98. Available from: https://pubmed.ncbi.nlm.nih.gov/16261252/Huertas N de J, Monroy ZJR, Medina RF, Castañeda JEG. Antimicrobial Activity of Truncated and Polyvalent Peptides Derived from the FKCRRWQWRMKKGLA Sequence against Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923. Mol A J Synth Chem Nat Prod Chem [Internet]. 2017 Jun 14 [cited 2021 Sep 16];22(6). Available from: /pmc/articles/PMC6152618/Roshanak S, Shahidi F, Tabatabaei Yazdi F, Javadmanesh A, Movaffagh J. Buforin I an alternative to conventional antibiotics: Evaluation of the antimicrobial properties, stability, and safety. Microb Pathog [Internet]. 2021 Dec 1 [cited 2021 Dec 2];161:105301. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0882401021005751Park CB, Kim MS, Kim SC. A novel antimicrobial peptide from Bufo bufo gargarizans. Biochem Biophys Res Commun. 1996 Jan 5;218(1):408–13.Park CB, Kim HS, Kim SC. Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun. 1998 Mar 6;244(1):253–7.Pavia KE, Spinella SA, Elmore DE. Novel Histone-Derived Antimicrobial Peptides Use Different Antimicrobial Mechanisms. Biochim Biophys Acta [Internet]. 2012 Mar [cited 2021 Dec 2];1818(3):869. Available from: /pmc/articles/PMC3273674Castañeda HM. Péptidos Quiméricos Derivados De La Lactoferricina Bovina Y La Buforina: Síntesis, Caracterización Y Evaluación De Su Actividad Antibacteriana. Tesis Maest [Internet]. 2019 [cited 2021 Dec 2];34. Available from: https://repositorio.unal.edu.co/handle/unal/76691Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Ninth Edition. [Internet]. CLSI document M07-A9(2012.). [cited 2021 Sep 16]. Available from: https://clsi.org/media/1928/m07ed11_sample.pdfM26-A Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline This document provides procedures for determining the lethal activity of antimicrobial agents. 1999 [cited 2021 Sep 16]; Available from: www.clsi.org.Solarte VA, Rosas JE, Rivera ZJ, Arango-Rodríguez ML, García JE, Vernot JP. A tetrameric peptide derived from bovine lactoferricin exhibits specific cytotoxic effects against oral squamous-cell carcinoma cell lines. Biomed Res Int [Internet]. 2015;2015. Available from: http://dx.doi.org/10.1155/2015/630179Ježíková Z, Pagáč T, Víglaš J, Pfeiferová B, Šoltys K, Bujdáková H, et al. Synergy Over Monotherapy. Curr Microbiol [Internet]. 2019 Apr 2 [cited 2022 Feb 16];76(6):673–7. Available from: https://link.springer.com/article/10.1007/s00284-019- 01678-9Wei G-X, Campagna AN, Bobek LA. Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide. Ann Clin Microbiol Antimicrob 2007 61 [Internet]. 2007 Nov 11 [cited 2021 Sep 16];6(1):1–10. Available from: https://annclinmicrob.biomedcentral.com/articles/10.1186/1476-0711-6-14Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical Microbiology E, Diseases I. Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin Microbiol Infect [Internet]. 2000 Sep 1 [cited 2022 Jan 21];6(9):503–8. Available from:Lakshminarayanan R, Liu S, Li J, Nandhakumar M, Aung TT, Goh E, et al. Synthetic Multivalent Antifungal Peptides Effective against Fungi. PLoS One [Internet]. 2014 Feb 3 [cited 2022 Feb 24];9(2):87730. Available from: /pmc/articles/PMC3912015/Yang C, Guo S, Wu X, Yang P, Han L, Dai X, et al. Multiscale study on the enhancing effect and mechanism of borneolum on transdermal permeation of drugs with different log P values and molecular sizes. Int J Pharm. 2020 Apr 30;580:119225.Klubthawee N, Adisakwattana P, Hanpithakpong W, Somsri S, Aunpad R. A novel, rationally designed, hybrid antimicrobial peptide, inspired by cathelicidin and aurein, exhibits membrane-active mechanisms against Pseudomonas aeruginosa. Sci Rep [Internet]. 2020;10(1). Available from: www.nature.com/scientificreportsArfa A Ben, Combes S, Preziosi-Belloy L, Gontard N, Chalier P. Antimicrobial activity of carvacrol related to its chemical structure.Wade HM, Darling LEO, Elmore DE. Hybrids Made from Antimicrobial Peptides with Different Mechanisms of Action Show Enhanced Membrane Permeabilization. Biochim Biophys acta Biomembr [Internet]. 2019 Oct 1 [cited 2022 Jan 21];1861(10):182980. Available from: /pmc/articles/PMC6721965/Wade HM, Darling LEO, Elmore DE. Hybrids Made from Antimicrobial Peptides with Different Mechanisms of Action Show Enhanced Membrane Permeabilization. Biochim Biophys acta Biomembr [Internet]. 2019 Oct 1 [cited 2022 Jan 21];1861(10):182980. Available from: /pmc/articles/PMC6721965/Pineda HM. PÉPTIDOS QUIMÉRICOS DERIVADOS DE LA LACTOFERRICINA BOVINA Y LA BUFORINA: SÍNTESIS, CARACTERIZACIÓN Y EVALUACIÓN DE SU ACTIVIDAD ANTIBACTERIANA. 2019;Vega Chaparro SC, Valencia Salguero JT, Martínez Baquero DA, Rosas Pérez JE. Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens. Biomed Res Int [Internet]. 2018 [cited 2022 Jan 21];2018. Available from: /pmc/articles/PMC6015718/Lai YW, Campbell LT, Wilkins MR, Pang CNI, Chen S, Carter DA. Synergy and antagonism between iron chelators and antifungal drugs in Cryptococcus. Int J Antimicrob Agents. 2016 Oct 1;48(4):388–94.Candida albicansQuimerasLactoferricina bovinaBuforinaIIPéptidos antimicrobianosLICENSElicense.txtlicense.txttext/plain; charset=utf-814828https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/5/license.txt2f9959eaf5b71fae44bbf9ec84150c7aMD55open accessTEXTEvaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bov[Mateo] (1).pdf.txtEvaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bov[Mateo] (1).pdf.txtExtracted texttext/plain123296https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/6/Evaluaci%c3%b3n%20de%20la%20actividad%20anti-Candida%20de%20p%c3%a9ptidos%20quim%c3%a9ricos%20ramificados%20derivados%20de%20Lactoferricina%20Bov%5bMateo%5d%20%281%29.pdf.txt4e7a94a34caa1d7390bfc54225099a3cMD56open accesspresentacion trabajo de grado 2.pptx.pdf.txtpresentacion trabajo de grado 2.pptx.pdf.txtExtracted texttext/plain15236https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/8/presentacion%20trabajo%20de%20grado%202.pptx.pdf.txt882f44b3e9e294627f1ac08b059f4339MD58open accessFORMATO IDENTIFICACIÓN TRABAJOS DE GRADO MATEO MARQUEZ-FIRMADO.pdf.txtFORMATO IDENTIFICACIÓN TRABAJOS DE GRADO MATEO MARQUEZ-FIRMADO.pdf.txtExtracted texttext/plain3048https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/10/FORMATO%20IDENTIFICACI%c3%93N%20TRABAJOS%20DE%20GRADO%20MATEO%20MARQUEZ-FIRMADO.pdf.txtccae006dc3d4be181d0e244d996aadcfMD510metadata only accessCARTA DERECHOS DE AUTOR Marquez.pdf.txtCARTA DERECHOS DE AUTOR Marquez.pdf.txtExtracted texttext/plain1113https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/12/CARTA%20DERECHOS%20DE%20AUTOR%20Marquez.pdf.txt168374500082517f2356b8ae3d4a9f59MD512metadata only accessTHUMBNAILEvaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bov[Mateo] (1).pdf.jpgEvaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bov[Mateo] (1).pdf.jpgGenerated Thumbnailimage/jpeg5773https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/7/Evaluaci%c3%b3n%20de%20la%20actividad%20anti-Candida%20de%20p%c3%a9ptidos%20quim%c3%a9ricos%20ramificados%20derivados%20de%20Lactoferricina%20Bov%5bMateo%5d%20%281%29.pdf.jpge4a7f45db4818edfb1aa57b8e497188cMD57open accesspresentacion trabajo de grado 2.pptx.pdf.jpgpresentacion trabajo de grado 2.pptx.pdf.jpgGenerated Thumbnailimage/jpeg8003https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/9/presentacion%20trabajo%20de%20grado%202.pptx.pdf.jpg105e1959755d7bb68cc2c107cd37f4d3MD59open accessFORMATO IDENTIFICACIÓN TRABAJOS DE GRADO MATEO MARQUEZ-FIRMADO.pdf.jpgFORMATO IDENTIFICACIÓN TRABAJOS DE GRADO MATEO MARQUEZ-FIRMADO.pdf.jpgGenerated Thumbnailimage/jpeg13731https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/11/FORMATO%20IDENTIFICACI%c3%93N%20TRABAJOS%20DE%20GRADO%20MATEO%20MARQUEZ-FIRMADO.pdf.jpg179a3cea852b96ddd491eee59d563bd8MD511metadata only accessCARTA DERECHOS DE AUTOR Marquez.pdf.jpgCARTA DERECHOS DE AUTOR Marquez.pdf.jpgGenerated Thumbnailimage/jpeg9295https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/13/CARTA%20DERECHOS%20DE%20AUTOR%20Marquez.pdf.jpgb95e76cb36aa6fcefebb96d741e327b8MD513metadata only accessORIGINALEvaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bov[Mateo] (1).pdfEvaluación de la actividad anti-Candida de péptidos quiméricos ramificados derivados de Lactoferricina Bov[Mateo] (1).pdfapplication/pdf2163548https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/14/Evaluaci%c3%b3n%20de%20la%20actividad%20anti-Candida%20de%20p%c3%a9ptidos%20quim%c3%a9ricos%20ramificados%20derivados%20de%20Lactoferricina%20Bov%5bMateo%5d%20%281%29.pdf812ae1d1bca7f1bc1ca79b6fd1e027bcMD514open accesspresentacion trabajo de grado 2.pptx.pdfpresentacion trabajo de grado 2.pptx.pdfapplication/pdf8422598https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/15/presentacion%20trabajo%20de%20grado%202.pptx.pdfdff1a2608ef0d538d6a06f6234c16bdaMD515open accessCARTA DERECHOS DE AUTOR Marquez.pdfCARTA DERECHOS DE AUTOR Marquez.pdfapplication/pdf154015https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/16/CARTA%20DERECHOS%20DE%20AUTOR%20Marquez.pdf60e3bd5d73d10d993bfb874db2e300beMD516metadata only accessFORMATO IDENTIFICACIÓN TRABAJOS DE GRADO MATEO MARQUEZ-FIRMADO.pdfFORMATO IDENTIFICACIÓN TRABAJOS DE GRADO MATEO MARQUEZ-FIRMADO.pdfapplication/pdf169584https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5715/17/FORMATO%20IDENTIFICACI%c3%93N%20TRABAJOS%20DE%20GRADO%20MATEO%20MARQUEZ-FIRMADO.pdfd0f6a4f88aba8b1af7d6651bda1e00c0MD517metadata only accessunicolmayor/5715oai:repositorio.unicolmayor.edu.co:unicolmayor/57152024-05-10 11:21:07.946An error occurred on the license name.|||https://creativecommons.org/licenses/by-nc-sa/4.0/open accessBiblioteca Digital Unicolmayorrepositorio@unicolmayor.edu.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

Publicaciones similares